Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Australia.
Institute for Breathing and Sleep, Austin Health, Heidelberg, Australia.
J Alzheimers Dis. 2020;78(2):611-617. doi: 10.3233/JAD-200571.
Obstructive sleep apnea (OSA) has been linked to an increase risk of dementia. Few studies have cross-sectionally examined whether clinically-confirmed OSA is associated with a higher brain amyloid burden.
The aim of this study was to compare brain amyloid burden in individuals with untreated OSA and healthy controls, and explore associations between amyloid burden and polysomnographic and subjective measures of sleep, demographics, and mood.
Thirty-four individuals with OSA (mean age 57.5±4.1 y; 19 males) and 12 controls (mean age 58.5±4.2 y; 6 males) underwent a clinical polysomnogram and a 11C-PiB positron emission tomography (PET) scan to quantify amyloid burden.
Amyloid burden was elevated in the OSA group relative to controls, and was significantly higher in those with severe OSA relative to mild/moderate OSA. Correlation analyses indicated that higher amyloid burden was associated with a higher Non-REM apnea hypopnea index, poorer sleep efficiency, and less time spent in stage N3 sleep, when controlling for age.
Severe OSA is associated with a modest elevation of brain amyloid, the significance of which should be further investigated to explore the implications for dementia risk.
阻塞性睡眠呼吸暂停(OSA)与痴呆风险增加有关。很少有研究从横断面上检查过临床确诊的 OSA 是否与更高的脑淀粉样蛋白负担有关。
本研究旨在比较未经治疗的 OSA 患者和健康对照者的脑淀粉样蛋白负担,并探讨淀粉样蛋白负担与多导睡眠图和睡眠的主观测量、人口统计学和情绪之间的关系。
34 名 OSA 患者(平均年龄 57.5±4.1 岁;19 名男性)和 12 名对照者(平均年龄 58.5±4.2 岁;6 名男性)接受了临床多导睡眠图和 11C-PiB 正电子发射断层扫描(PET)扫描,以定量淀粉样蛋白负担。
与对照组相比,OSA 组的淀粉样蛋白负担升高,且重度 OSA 组的淀粉样蛋白负担明显高于轻度/中度 OSA 组。相关分析表明,在控制年龄的情况下,较高的淀粉样蛋白负担与较高的非快速动眼睡眠呼吸暂停低通气指数、较差的睡眠效率和较少的 N3 睡眠时间有关。
重度 OSA 与脑淀粉样蛋白的适度升高有关,其意义应进一步研究,以探讨其对痴呆风险的影响。